[1]
D. Castillo-Gonzàles, I. Álvarez Sardiñas, C. Macías Abraham, and A. G. Muñoz Bedoya, “Emicizumab in hemophilia A with inhibitors: clinical and economic impact of its use in a Cuban patient”, AboutOpen, vol. 9, no. 1, pp. 83–86, Sep. 2022.